Novavax to Participate in 2026 Jefferies Global Healthcare Conference
Novavax (Nasdaq: NVAX) will participate in the 2026 Jefferies Global Healthcare Conference in New York, NY.
Rhea-AI Summary
Novavax (Nasdaq: NVAX) will participate in the 2026 Jefferies Global Healthcare Conference in New York, NY.
The company is scheduled for a fireside chat on Thursday, June 4, 2026, from 10:30–11:00 a.m. Eastern Time. A live webcast and 30-day replay will be available on its investor website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – NVAX
On Jun 2, the first trading day after this news, NVAX closed 2.85% below the previous close.
Data tracked by StockTitan Argus for the Jun 2 session.
Key Figures
- Conference date
- June 4, 2026
- Jefferies Global Healthcare Conference fireside chat date
- Start time
- 10:30 a.m. Eastern Time
- Fireside chat start time
- End time
- 11:00 a.m. Eastern Time
- Fireside chat end time
- Webcast replay window
- 30 days
- Duration webcast replay will be available
Historical Context
-
Announcement of participation in BofA Securities 2026 Health Care Conference.
-
Q1 2026 results with revenue down 79% year-over-year to $140M.
-
Scheduling announcement for Q1 2026 financial results and webcast details.
-
Appointment of Dr. Robert Walker as EVP and Head of R&D.
-
Plan to attend multiple March 2026 investor conferences with webcasts.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Details: | |
Fireside Chat | |
Date: | Thursday, June 4, 2026 |
Time: | 10:30 – 11:00 a.m. Eastern Time |
Location: | |
Recordings
A webcast of the fireside chat will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcast will be available for 30 days.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M® adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid, R21/Matrix-M™), Matrix technology and R&D assets. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Jim Kelly
844-668-2829
ir@novavax.com
Media
Yvonne Sprow
844-264-8571
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-2026-jefferies-global-healthcare-conference-302787486.html
SOURCE Novavax, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.